- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05216549
Water and Land-based Exercise for Children With Post COVID-19 Condition (postcovidkids)
The latest data indicate that post COVID-19 condition is frequent in children and adolescents, with the most common symptoms being fatigue, shortness of breath, exercise intolerance and weakness. Evidence that COVID-19 can have significant long-term effects on children's health highlights the need for measures to reduce the impact of the pandemic on children, ensuring that they receive appropriate treatments. Those experiencing post COVID-19 condition require more tailored exercise-related advice and improved support to be able to resume activities important to their individual well-being. To the best of our knowledge, no studies have yet addressed the issue of exercise programs for children with post COVID-19 condition.
The aim of this study, therefore, is to evaluate the effectiveness of different interventions on pulmonary function, exercise capacity, fatigue and quality of life in children with post COVID-19 condition.
This will be a randomized controlled study with pre and post intervention assessment. Children will be recruited from primary schools and primary health care units in Warsaw. Participants meeting the inclusion criteria will be randomized to one of 3 groups: water-based exercise, land-based exercise or control (no exercise). The water-based and land-based exercise groups will be held twice a week, 45 min per session for 8 weeks. Participants will be assessed at baseline and immediately post-intervention in terms of changes in pulmonary function, exercise capacity, fatigue and quality of life. Research outcomes will build the evidence-based practice for health professionals.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Warsaw, Poland, 00-968
- Jozef Pilsudski University of Physical Education in Warsaw
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- presenting symptoms of post-COVID-19 condition confirmed by the diagnosis by general practitioner (including obligatory fatigue and shortness of breath/respiratory problems)
- age 10-12 yrs old
- adapted to aquatic setting
- <12 pts in the Ruffier test
Exclusion Criteria:
- contraindications to exercise
- chest pain
- physical activity trainings more than 2 times per week one month prior the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Water-based exercise
The water-based exercise group will be held twice a week, 45 min per session for 8 weeks.
Supervised exercise will be led by the experienced physiotherapist and water-based exercise by physiotherapist with aquatic exercise expertise.Each session will consist of warm up (10 min), main part (30 min) and cool-down (5 min).
During warm up children will perform lower and upper limbs aerobics and breathing exercises.
The main part will consist of endurance exercises of upper and lower limbs with focus on breathing pattern.
During cool-down focus will be on upper limb and thoracic cage stretches and breathing control.
|
8 weeks x 2 times per week for 45 min
|
|
Experimental: Land-based exercise
The land-based exercise group will be held twice a week, 45 min per session for 8 weeks.
Supervised exercise will be led by the experienced physiotherapist and water-based exercise by physiotherapist with aquatic exercise expertise.Each session will consist of warm up (10 min), main part (30 min) and cool-down (5 min).
During warm up children will perform lower and upper limbs aerobics and breathing exercises.
The main part will consist of endurance exercises of upper and lower limbs with focus on breathing pattern.
During cool-down focus will be on upper limb and thoracic cage stretches and breathing control.
|
8 weeks x 2 times per week for 45 min
|
|
No Intervention: Control
The control group will be asked not to change their physical activity for 8 weeks.
After that period and post-test the control group will receive the exercise.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Exercise capacity
Time Frame: 8 weeks (post intervention)
|
Exercise capacity will be measured with the use of modification of the Balke treadmill protocol previously validated on a large population-based sample of children ages 7-18 years.
Breathing parameters will be measured continuously by the "breath-to breath" method using an ergospirometer Cortex MetaMax 3B system (Biophysik GmbH, Leipzig, Germany).
Output from the gas analyses will be sampled at 15 s intervals and stored for use in the calculation of the Oxygen-Uptake Efficiency Slope (OUES).
|
8 weeks (post intervention)
|
|
Fatigue
Time Frame: 8 weeks (post intervention)
|
The fatigue will be assessed with the Polish adaptation of the Chronic Fatigue Syndrome Questionnaire.
The questionnaire allows to determine the level of chronic fatigue and severity of individual symptoms: general fatigue, decreased vitality, mental overload, somatic symptoms, anxiety and discouragement.
It includes 59 statements with one of the possible answers: "never", "sometimes", "often" - the answers are assigned the values 0, 1, 2, respectively.
The higher the score, the greater the severity of the symptoms of chronic fatigue.
|
8 weeks (post intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Health-related quality of life
Time Frame: 8 weeks (post intervention)
|
Health-related quality of life will be assessed with the PedsQL - a brief, standardized, generic assessment instrument that systematically assesses perception of HRQOL in healthy children and adolescents and those with acute and chronic health conditions.
|
8 weeks (post intervention)
|
|
Forced vital capacity (FVC)
Time Frame: 8 weeks (post intervention)
|
FVC will be measured using the MES Lung Handy spirometer.
Measurements will be repeated three times at five-minute intervals, and the highest score will be selected for analysis.
|
8 weeks (post intervention)
|
|
Forced expiratory volume/one second (FEV 1)
Time Frame: 8 weeks (post intervention)
|
FEV 1 will be measured using the MES Lung Handy spirometer.
Measurements will be repeated three times at five-minute intervals, and the highest score will be selected for analysis.
|
8 weeks (post intervention)
|
|
Maximal expiratory flow at 25% of forced vital capacity (MEF25)
Time Frame: 8 weeks (post intervention)
|
MEF25 will be measured using the MES Lung Handy spirometer.
Measurements will be repeated three times at five-minute intervals, and the highest score will be selected for analysis.
|
8 weeks (post intervention)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Anna Ogonowska-Slodownik, PhD, Józef Piłsudski University of Physical Education in Warsaw
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BPN/GIN/2021/1/00071/U/00001
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COVID-19
-
PfizerActive, not recruitingCOVID-19 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | COVID-19 Vaccines | SARS-CoV-2 Infection, COVID19 | COVID-19 Vaccination | SARS-CoV-2 Infection, COVID-19 | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionUnited States
-
Shanghai Public Health Clinical CenterNot yet recruiting
-
Duke UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Eggensberger OHGBavarian Health and Food Safety Authority (LGL)RecruitingPost COVID-19 Condition | Post COVID-19 | Post COVID-19 Syndrome | Long COVID-19 Syndrome | Post COVID-19 Condition (PCC)Germany
-
PfizerRecruitingRespiratory Tract Diseases | COVID-19 | Pneumonia | Lung Diseases | Coronavirus Disease 2019 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | Upper Respiratory Tract Infections | Respiratory Tract Infection | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionBelgium
-
ModeX Therapeutics, An OPKO Health CompanyRecruitingCOVID -19 | COVID-19 (Prevention)United States
-
Lawson Research Institute of St. Joseph'sCanadian Institutes of Health Research (CIHR); Western University, CanadaRecruitingFatigue | Post-COVID-19 Syndrome | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19 | Long-COVID | Post-COVID ConditionCanada
-
RSUP PersahabatanCompletedPost COVID-19 Syndrome | Long COVID-19 Syndrome | Post COVID Syndrome Long CovidIndonesia
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico; Bios Prevention SrlCompletedPost Acute Sequelae of COVID-19 | Post COVID-19 Condition | Long-COVID | Chronic COVID-19 SyndromeItaly
-
Yang I. PachankisActive, not recruitingCOVID-19 Respiratory Infection | COVID-19 Stress Syndrome | COVID-19 Vaccine Adverse Reaction | COVID-19-Associated Thromboembolism | COVID-19 Post-Intensive Care Syndrome | COVID-19-Associated StrokeChina
Clinical Trials on Water-based exercise
-
Mariano Marcos State UniversityCompleted
-
University of BradfordSt George's University Hospitals NHS Foundation TrustCompletedPregnancy Related | Pelvic Girdle PainUnited Kingdom
-
Chulalongkorn UniversityCompleted
-
University Medical Centre LjubljanaKRKACompletedCoronary Artery DiseaseSlovenia
-
Universidade Metodista de PiracicabaCompletedArteriosclerosis, CoronaryBrazil
-
Istanbul Medipol University HospitalNot yet recruiting
-
Universidade Metodista de PiracicabaUnknownArteriosclerosis, CoronaryBrazil
-
Universidade Estadual Paulista Júlio de Mesquita...Fundação de Amparo à Pesquisa do Estado de São PauloRecruiting